Cocrystal Pharma, Inc. — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2016-03-15

Reporting Person: HSIAO JANE PH D (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-15	Common Stock	P	1235294	$0.51	Acquired	3435294	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5496654	Indirect

Footnotes

F1: The securities are owned directly by Hsu Gamma Investment, L.P., of which the reporting person is the general partner. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose